美股市場個股詳情

OCUL Ocular Therapeutix

添加自選

4.745
+0.545+12.98%

收盤價 04/26 16:00 (美東)

4.752
+0.007+0.14%

盤前 09:09 (美東)

7.34億總市值-4651市盈率TTM

Ocular Therapeutix股票討論區

登錄發表評論

Trytosaveabit

04/19 03:29

Color me completely confused on this! Hehehe!

$Ocular Therapeutix(OCUL.US)$ Have zero clue to this price action? Truly i can not figure why! Oh well lets see where it lands then decide whether to buy or wait?

Trytosaveabit

04/19 01:51

OMG! Hehehe!

$Ocular Therapeutix(OCUL.US)$ These results are actually really good! ZERO patients in control/placebo group had any improvement! But the actual group! Well here look for yourself! Then keep in mind coming into today there’s almost 12 million shares sold short! With 14 DTC at this volume! Hehehe! but I digress! Hehehe! (((((((((((((. Ocular Therapeutix (NASDAQ:OCUL) announced Thursday that its Phase 1 HELIOS ...

Trytosaveabit

04/18 19:02

Update

$Ocular Therapeutix(OCUL.US)$ Ocular Therapeutix - 46.2% of Patients Showed a 1- or 2-Step Improvement in Diabetic Retinopathy Severity Scale (Drss) at 40 Weeks in Axpaxli Arm
Ocular Therapeutix Inc - No Patients in Axpaxli Group Experienced Worsening in Drss Compared to 12.5% in Control Arm at 40 Weeks

ApextradezCOM

04/15 23:31

ApexTradez dot com 🫵🏻💥💯

$Ocular Therapeutix(OCUL.US)$
BofA has OCUL BUY PT 15 see the update positively given by Dr. Dugel's who’s expertise in retinal disease drug development. solid pwrsoective meanwhile we now await the upcoming readout of the phase 1 HELIOS trial in NPDR as the next BIG catalyst for the company
***** buy the RED day Dips and win?!? join to win a free Swing Channel for (6) months only 9 slots left from the 100 offered this morning in another platform.
$Beamr Imaging(BMR.US)$ Tomorrow...

Moomoo AI

03/07 10:41

Despite strong revenue, the high P/S ratio suggests potential overvaluation. Investors' bullishness may lead to disappointment if P/S aligns with growth outlook. The share price risks decline due to mediocre revenue forecasts.

Ocular Therapeutix, Inc.'s (NASDAQ:OCUL) Shares Climb 111% But Its Business Is Yet to Catch Up

SlowndEasyTrades

03/04 23:13

$Ocular Therapeutix(OCUL.US)$ 👀 new deep high of the month !

Moomoo AI

03/02 07:41

Petrus Advisers views Criteo as an 'attractive investment opportunity' that could be strengthened by requested actions. Ocular Therapeutix's leadership changes are seen as a positive step towards becoming a leader in retina care. Starboard previously labeled Fortrea shares as 'undervalued' and an 'attractive investment opportunity'.

Criteo, Ocular Therapeutix, and More Stocks See Action From Activist Investors -- Barrons.com

Stock Region

02/23 08:31

$325 Million Private Placement Secured By Propeling Medical Company

($OCUL) - The Impact on Ocular Therapeutix.
This funding is expected to significantly propel the company's research and development endeavors, especially the clinical development of AXPAXLI™ for wet AMD treatment. Wet AMD is a chronic eye disorder that causes blurred vision or a blind spot in your visual field. It's generally caused by abnormal blood vessels that leak fluid or blood into the region of the macula. $Ocular Therapeutix(OCUL.US)$
...